Average Co-Inventor Count = 2.44
ph-index = 15
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Cell Pathways (67 from 75 patents)
2. University of Arizona (7 from 972 patents)
3. Osi Pharmaceuticals, Inc. (3 from 118 patents)
4. Other (2 from 832,680 patents)
5. Michigan State University (1 from 1,415 patents)
6. Midway Pharmaceuticals, Inc (1 from 1 patent)
7. Fgn, Inc. (1 from 1 patent)
74 patents:
1. 10045949 - Managing osteoporosis with HMW PEG
2. 7115647 - Method of inhibiting neoplastic cells with indole derivatives
3. 6875575 - Diagnostic methods for neoplasia
4. 6869944 - Method for treating a patient with neoplasia by treatment with a platinum coordination complex
5. 6610854 - Substituted condensation products of N-benzyl-3-indenylacentamides with heterocyclic aldehydes for neoplasia
6. 6562830 - Method of treating a patient having precancerous lesions with phenyl quinazolinone derivatives
7. 6555547 - Method for treating a patient with neoplasia by treatment with a vinca alkaloid derivative
8. 6500610 - Methods for identifying compounds for inhibiting of neoplastic lesions, and pharmaceutical compositions containing such compounds
9. 6486158 - [4,5]-fused-3,6-disubstituted-pyridazines with sulfur-containing substituents in position three for the treatment of neoplasia
10. 6486155 - Method of inhibiting neoplastic cells with isoquinoline derivatives
11. 6479520 - Method of treating a patient having precancerous lesions with phenyl pyridinone derivatives
12. 6472420 - Method for treating a patient with neoplasia by treatment with a paclitaxel derivative
13. 6455703 - 1,3,6,-Trihydro-6-aza-3-oxapentalen-2-one derivatives for the treatment of neoplasia
14. 6440981 - Method for inhibiting neoplastic cells and related conditions by exposure to 2,9-disubstituted purin-6-ones
15. 6432950 - Method for inhibiting neoplastic cells and related conditions by exposure to benzothienopyrimidine derivatives